Stock INTEG B INTEGRUM AB
Add to a list
To use this feature you must be a member
Log inSign up

Financials Integrum AB

Equities

INTEG B

SE0009807266

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Stockholm
Other stock markets
 10:57:19 2024-05-24 am EDT 		5-day change 1st Jan Change
53.4 SEK -0.37% Intraday chart for Integrum AB -2.20% +16.98%
May. 15 Integrum Announces It Has Been Granted A Registered Trademark for OPRA® Implant System in the Eu CI
May. 02 Integrum Expands Its Product Offering to the United Kingdom Market CI

Valuation

Fiscal Period: April 2021 2022 2023 2024 2025 2026
Capitalization 1 871.1 757.6 476.3 984.4 - -
Enterprise Value (EV) 1 871.1 682.5 434.4 961.7 964.6 937.7
P/E ratio - 35.9 x -131 x 728 x 70.9 x 40.3 x
Yield - - - - - -
Capitalization / Revenue 16.4 x 9.88 x 6.41 x 9.2 x 6.52 x 4.54 x
EV / Revenue 16.4 x 8.9 x 5.85 x 8.98 x 6.39 x 4.33 x
EV / EBITDA - 296 x -23.4 x 124 x 53.2 x 28.2 x
EV / FCF - -13.7 x -40.8 x -55 x -175 x 49.4 x
FCF Yield - -7.28% -2.45% -1.82% -0.57% 2.03%
Price to Book - - - 6.65 x 6.17 x 5.35 x
Nbr of stocks (in thousands) 15,838 18,038 18,215 18,435 - -
Reference price 2 55.00 42.00 26.15 53.40 53.40 53.40
Announcement Date 5/31/21 6/10/22 6/8/23 - - -
1SEK in Million2SEK
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: April 2021 2022 2023 2024 2025 2026
Net sales 1 53.01 76.68 74.27 107 151 216.6
EBITDA 1 - 2.303 -18.55 7.76 18.14 33.24
EBIT 1 - 1.039 -19.7 5.65 17.59 37.1
Operating Margin - 1.35% -26.53% 5.28% 11.64% 17.13%
Earnings before Tax (EBT) 1 - 1.185 -21.52 5.627 17.64 30.28
Net income 1 -0.6017 21.27 - 4.38 15.69 24.24
Net margin -1.14% 27.74% - 4.09% 10.39% 11.19%
EPS 2 - 1.170 -0.2000 0.0733 0.7533 1.325
Free Cash Flow 1 - -49.66 -10.66 -17.5 -5.5 19
FCF margin - -64.76% -14.35% -16.35% -3.64% 8.77%
FCF Conversion (EBITDA) - - - - - 57.16%
FCF Conversion (Net income) - - - - - 78.38%
Dividend per Share 2 - - - - - -
Announcement Date 5/31/21 6/10/22 6/8/23 - - -
1SEK in Million2SEK
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: April 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2 2025 Q3 2025 Q4
Net sales 1 15.21 20.47 25.07 25.18 32.4 22.11 18.13 20.4 27.56 30.11 29.2 31.7 35.8 40.55 42
EBITDA 1 - - - - - - - - - - 2 3 4 5 6
EBIT 1 -0.243 0.503 -0.468 0.366 0.873 -13.77 -7.171 -2.925 6.454 0.34 2.95 3.5 3.95 5.15 5
Operating Margin -1.6% 2.46% -1.87% 1.45% 2.69% -62.3% -39.55% -14.34% 23.42% 1.13% 10.1% 11.04% 11.03% 12.7% 11.9%
Earnings before Tax (EBT) 1 - 0.541 -0.317 - - - - - - - 1 2 3 4 5
Net income 1 - 0.532 3.273 - - - - - - - 1 2 3 4 4
Net margin - 2.6% 13.06% - - - - - - - 3.42% 6.31% 8.38% 9.86% 9.52%
EPS 2 - - - - - - - - - - 0.0600 0.0900 0.1400 0.1900 0.2100
Dividend per Share - - - - - - - - - - - - - - -
Announcement Date 12/2/21 3/2/22 6/10/22 8/31/22 12/1/22 3/1/23 6/8/23 8/31/23 12/4/23 2/29/24 - - - - -
1SEK in Million2SEK
Estimates

Balance Sheet Analysis

Fiscal Period: April 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - - - -
Net Cash position 1 - 75.1 41.9 22.8 19.8 46.8
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 - -49.7 -10.7 -17.5 -5.5 19
ROE (net income / shareholders' equity) - 23.1% -2.46% 1.05% 3.89% 7.27%
ROA (Net income/ Total Assets) - - - - - -
Assets 1 - - - - - -
Book Value Per Share 2 - - - 8.030 8.660 9.990
Cash Flow per Share - - - - - -
Capex 1 - 29.3 11.4 5.5 6 12
Capex / Sales - 38.17% 15.35% 5.14% 3.97% 5.54%
Announcement Date 5/31/21 6/10/22 6/8/23 - - -
1SEK in Million2SEK
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Integrum AB

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical Prosthetics

1st Jan change Capi.
INTEGRUM AB Stock Integrum AB
+16.98% 92.46M
SONOVA HOLDING AG Stock Sonova Holding AG
+7.22% 19.19B
COCHLEAR LIMITED Stock Cochlear Limited
+7.49% 13.94B
DEMANT A/S Stock Demant A/S
+11.01% 10.41B
EYEBRIGHT MEDICAL TECHNOLOGY (BEIJING) CO., LTD. Stock Eyebright Medical Technology (Beijing) Co., Ltd.
-17.87% 2.05B
EMBLA MEDICAL HF. Stock Embla Medical hf.
+3.83% 1.77B
ANGELALIGN TECHNOLOGY INC. Stock Angelalign Technology Inc.
+19.19% 1.46B
MODERN DENTAL GROUP LIMITED Stock Modern Dental Group Limited
+12.79% 588M
ANGEL ROBOTICS CO., LTD. Stock Angel Robotics Co., Ltd.
0.00% 419M
DELCATH SYSTEMS, INC. Stock Delcath Systems, Inc.
+87.02% 216M
Medical Prosthetics
  1. Stock Market
  2. Equities
  3. INTEG B Stock
  4. Financials Integrum AB